MedPath

ARANESP -(HSA-FREE)

ARANESP -(HSA-FREE)

Discontinued
DIN Number

02246360

Drug Class

Human

Market Date

Aug 13, 2002

Company
HC

Amgen Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02246360
AIG Number0148081008
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
B03XA02 DARBEPOETIN ALFA
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous ,  Subcutaneous
AHFS Classification20:16.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

DARBEPOETIN ALFAActive
Strength: 500 MCG / ML
Monograph: DARBEPOETIN ALFA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.